Aclarubicin Active Not Recruiting Phase 1 Trials for Vasculopathy, Retinal, With Cerebral Leukodystrophy / Cerebroretinal Vasculopathy, Hereditary Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02723448Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy